Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicines set out in the Schedule hereto:
Schedule
Product: Aspen Adrenaline
Active Ingredient: Adrenaline 1mg/10mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Biologici Italia Laboratoires Srl, Novate Milanese, Milan, Italy
Biologici Italia Laboratoires Srl, Masate, Milan, Italy
Product: DBL Docetaxel, Concentrated Injection
Active Ingredient: Docetaxel 10mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Hospira NZ Limited
Manufacturers: Hospira Australia Pty Limited, Mulgrave, Australia
Zydus Hospira Oncology Limited (ZHOPL), Ahmedabad, India
Product: Telfast Children’s Elixir
Active Ingredient: Fexofenadine hydrochloride 6mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: sanofi-aventis us llc, Missouri, United States of America
Dated this 28th day of July 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).